Doxepin plasma concentrations: Is there really a therapeutic range?

Journal of Clinical Psychopharmacology

Volumn 21, Issue 4, 2001, Pages 432-439

  Leucht, Stefan ^a   Steimer, Werner ^b   Kreuz, Stefan ^a   Abraham, Dorothee ^a   Orsulak, Paul J ^c   Kissling, Werner ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXEPIN;

ARTICLE; CLINICAL PRACTICE; DATA ANALYSIS; DATA BASE; DEPRESSION; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MEDICAL LITERATURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DOXEPIN; FEMALE; GERMANY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 0034922147     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200108000-00011     Document Type: Article

References (32)

1. The Texas medication algorithm project: Report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder
2. Therapeutic drug monitoring of tricyclic antidepressants
3. Therapeutic drug monitoring. Principles and practice
4. Antidepressant plasma levels and clinical response in depressed patients treated with oxaprotiline and doxepin
5. Therapeutic superiority of maprotiline versus doxepin in geriatric depression
6. Standards of laboratory practice: Anti-depressant drug monitoring
7. Therapeutic drug monitoring of antidepressant drugs: Guidelines updated
8. Indications and guidelines for plasma tricyclic antidepressant monitoring
9. Low serum levels of tricyclic anti-depressants in amitriptyline and doxepin-treated inpatients with depressive syndrome are associated with nonresponse
10. Clinical importance of doxepin antidepressant plasma levels
11. Relationship between tricyclic antidepressant plasma levels and clinical response in patients treated with desipramine or doxepin
12. Should plasma level monitoring of tricyclic antidepressants be introduced in clinical practice?
13. Multiple-dose doxepin kinetics in depressed patients
14. Relationship of blood levels of Sinequan® to clinical effects in the treatment of depression in aged patients
15. Doxepin and desmethyldoxepin serum levels and clinical response
16. Clomipramine and doxepin in depressive neurosis. Plasma levels and therapeutic response
17. Doxepin plasma levels and anxiolytic response
18. Doxepin plasma levels and therapeutic response in depression: Preliminary findings
19. Research diagnostic criteria: Rational and reliability
20. A rating scale of depression
21. A self-rating depression scale
22. An inventory for measuring depression
23. The clinical utility of tricyclic antidepressant blood levels: A review of the literature
24. Mood disorders: Somatic treatments
25. Cis- and trans-isomers of doxepin and desmethyldoxepin in the plasma of depressed patients treated with doxepin
26. Doxepin plasma concentrations in clinical practice. Could there be a pharmacokinetic explanation for low concentrations?
27. Anticholinergic activity in the serum of patients receiving maintenance amitriptyline or doxepin therapy
28. Doxepin kinetics
29. Central nervous system toxicity of tricyclic antidepressants: Phenomenology, course, risk factors, and role of therapeutic drug monitoring